Contineum Therapeutics (CTNM) Ownership - Who owns Contineum Therapeutics?
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CTNM showed earnings on August 06, 2025. You can read more about the earnings report here.